The biotech market in the United States is experiencing a rapid surge in requirement for Tirzepatide APIs. This powerful medication, used to treat insulin resistance, has captured remarkable attention from both patients and healthcare professionals. As a result, numerous companies have emerged as producers of Tirzepatide APIs in the USA. Well-kn